TABLE 2.
Subgroups | Linear relationship (P value) | Slope (P value, estimate) | Intercept (P value, estimate) | |
---|---|---|---|---|
Male subjects | ||||
VO2max |
(ND, E4) vs (ND, Non E4) |
.044 |
.044 −1.481 |
|
(AD, E4) vs (AD, Non E4) |
.044 |
.044 −1.481 |
||
OUES |
(ND, E4) vs (ND, Non E4) |
.026 |
0.009 16.855 |
.012 −1133.793 |
(AD, E4) vs (AD, Non E4) |
<.001 |
0.009 16.855 |
.002 −1430.924 |
|
Female subjects | ||||
VO2 max |
(ND, E4) vs (ND, Non E4) |
.124 |
0.101 0.144 |
.044 −1.481 |
(AD, E4) vs (AD, Non E4) |
.124 |
0.295 −0.291 |
.044 −1.481 |
|
OUES |
(ND, E4) vs (ND, Non E4) |
.026 |
0.009 16.855 |
.012 −1133.793 |
(AD, E4) vs (AD, Non E4) |
<.001 |
0.009 16.855 |
.002 −1430.924 |
Notes: Regression model values are given for cardiorespiratory fitness outcomes using threshold P = .015 for backward elimination.
Abbreviations: CRF, cardiorespiratory fitness; OUES, oxygen uptake efficiency slope.